Explore All Access
Check if your research matches the topics covered in Chinese Clinical Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Chinese Clinical Oncology : Impact Factor & More
eISSN: 2304-3873pISSN: 2304-3865
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Chinese Clinical Oncology Key Metrics
CiteScore 
4.2
SJR
Q3Oncology
SNIP
1.03
Topics Covered on Chinese Clinical Oncology
Cancer
Meningioma
Breast cancer
Lymphatic system
Gynecologic cancer
Hepatocellular carcinoma
Soft tissue sarcoma
Ramucirumab
Immunotherapy
Gallbladder
Sentinel lymph node
Retroperitoneal sarcoma
Vomiting
Gallbladder cancer
Middle East
Observational study
Debulking
Glioblastoma
Alveolar soft part sarcoma
Progression-free survival
Chinese Clinical Oncology Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chinese Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Clinical Oncology
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma.
- 10 Oct 2024
- Chinese clinical oncology
Current status, evolution, and future perspectives in robotic platform systems for prostate cancer treatment: a narrative review.
- 8 Oct 2024
- Chinese clinical oncology
Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?
- 1 Oct 2024
- Chinese Clinical Oncology
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative review.
- 1 Oct 2024
- Chinese clinical oncology
A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer.
- 1 Oct 2024
- Chinese clinical oncology
Short-term outcomes in obese and non-obese patients undergoing transperitoneal laparoscopic adrenalectomy for benign or malignant adrenal diseases: an updated systematic review and meta-analysis.
- 1 Oct 2024
- Chinese clinical oncology
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma.
- 10 Oct 2024
- Chinese clinical oncology
Current status, evolution, and future perspectives in robotic platform systems for prostate cancer treatment: a narrative review.
- 8 Oct 2024
- Chinese clinical oncology
Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?
- 1 Oct 2024
- Chinese Clinical Oncology
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative review.
- 1 Oct 2024
- Chinese clinical oncology
A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer.
- 1 Oct 2024
- Chinese clinical oncology
Short-term outcomes in obese and non-obese patients undergoing transperitoneal laparoscopic adrenalectomy for benign or malignant adrenal diseases: an updated systematic review and meta-analysis.
- 1 Oct 2024
- Chinese clinical oncology
Compare Similar Journals with Chinese Clinical Oncology
Select Journals to Compare with Chinese Clinical Oncology
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Cancers
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
BMC Cancer
Publisher: BMC
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Annals of Surgical Oncology
Publisher: SPRINGER
Medicine
Publisher: Elsevier
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
Chinese Clinical Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Chinese Clinical Oncology
How long has Chinese Clinical Oncology been actively publishing? 
Chinese Clinical Oncology has been in operation since 2012 till date.
What is the publishing frequency of Chinese Clinical Oncology?
Chinese Clinical Oncology published with a Quarterly frequency.
How many articles did Chinese Clinical Oncology publish last year?
In 2023, Chinese Clinical Oncology publsihed 90 articles.
What is the eISSN & pISSN for Chinese Clinical Oncology?
For Chinese Clinical Oncology, eISSN is 2304-3873 and pISSN is 2304-3865.
What is Citescore for Chinese Clinical Oncology?
Citescore for Chinese Clinical Oncology is 4.2.
What is SNIP score for Chinese Clinical Oncology?
SNIP score for Chinese Clinical Oncology is 1.03.
What is the SJR for Chinese Clinical Oncology?
SJR for Chinese Clinical Oncology is Q3.
Who is the publisher of Chinese Clinical Oncology?
AME PUBLISHING COMPANY is the publisher of Chinese Clinical Oncology.
